AzTrials
AzTrials

StrokemCIMTNCT06692569

The Effect of Modified Constraint Induced Movement Therapy on Upper Extremity Function in Stroke Rehabilitation

A study testing Conventional Physical Therapy and Modified Constraint Induced Movement Therapy in people with Stroke and Hemiplegia, run by University of Jazan at 1 site in Saudi Arabia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of the study is to determine the effect of Modified Constraint-Induced Movement Therapy and trunk restraint contrasted with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients. Read more about this study

Who is it for?
Ages 45 to 65 years
Conditions the study is for
Stroke, Hemiplegia, Chronic Stroke Patients
What is being tested?
Conventional Physical Therapy and Modified Constraint Induced Movement Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteSaudi Arabia
Study dates
12 Nov 2024to 13 Jul 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Right or left-sided chronic hemiplegic patients.
  • Onset of stroke More than six months.
  • Age between 45 to 65 years of both genders.
  • Mini-Mental State Examination - Scored more than 24/30.
  • Modified Ashworth Scale for spasticity 1 or 1+.
  • Have at least 20° wrist active extension and at least 10° of metacarpophalangeal active extension of the paretic upper extremity.
Show all 9Show fewer
  • Have at least grade 2/5 of muscle power on upper extremity especially in wrist extensors.
  • Have normal visual perception.
  • With no other neurological disorders.

Who cannot join

  • Unable to follow visual and oral commands.
  • Unilateral neglect.
  • Severe cognitive, or language deficits.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mohammed Mansour Al Shehri, PhD contact

00966-503946253

moalshehri@jazanu.edu.sa

Saudi Arabia1 site, 1 recruiting
  • Majmaah Rehabilitation center

    Riyadh, Riyadh Region

    Center head, 016-4041122, aalanazi@mu.edu.sa

    Recruiting

Other trials in Saudi Arabia

About this study

The purpose of the study is to determine the effect of Modified Constraint-Induced Movement Therapy and trunk restraint contrasted with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.

  • To find out the effectiveness of conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
  • To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint along with conventional physical therapy treatment on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
  • To find out the effectiveness of modified constraint induced movement therapy (mCIMT) and trunk restraint combined with conventional physical therapy treatment versus conventional physical therapy treatment alone on improving upper extremity function, balance, and quality of life among chronic hemiplegic patients.
Being tested
Conventional Physical Therapy, Modified Constraint Induced Movement Therapy
Keywords
stroke, hemiplegia, constraint induced movement therapy, modified constraint induced movement therapy, trunk restrain, upper extremity motor function
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional Physical TherapyOther

    The conventional Physical Therapy, the treatment will be based on the client's capabilities. It included functional reeducation, muscle strengthening and stretching, muscle tone regulation methods, and training for activities of daily living

  • Modified Constraint Induced Movement TherapyOther

    Modified Constraint Induced Movement Therapy (mCIMT) which involves trunk constraint along with conventional Physical Therapy treatment. Under the attentive guidance of a physiotherapist, the patient engages in specific hand activities aligned with personalized goals. These activities encompass tasks such as picking up marbles, flipping cards, stacking blocks, combing hair, writing, and other actions relevant to daily life. The difficulty level is dynamically adjusted according to the patient's abilities and progress during the training sessions.Tasks may vary from one patient to another, and each session introduces fresh, goal-oriented challenges to further enhance rehabilitation outcomes, along with the conventional physical therapy treatment. The patients were wearing a trunk west which had a Velcro strap on the non-effected side part of the west, and it was attached to the Velcro straps on the non-affected part on the back support of the treatment chair.

Study groups in NCT06692569
Study groupRoleWhat they receive
ControlActive comparatorConventional Physical Therapy
Receives: Other: Conventional Physical Therapy
ExperimentalExperimentalConventional Physical Therapy and modified constraint induced movement therapy
Receives: Other: Modified Constraint Induced Movement Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wolf Motor Function Test

    Wolf Motor Function Test assessment tool was specifically developed to assess and evaluate the exercise capacity of individuals with varying degrees of upper extremity motion impairments, ranging from mild to severe, in both laboratory and clinical settings. It represents an enhancement over a previous tool that was more suitable for assessing high-functioning patients but posed challenges when used with individuals who had limited hand and finger mobility

    Measured: Week 0 and week 6

  2. Berg Balance Scale

    The Berg Balance Scale (BBS) is a widely used clinical assessment tool designed to evaluate and quantify an individual's balance and stability during various tasks. It consists of a series of 14 tasks or activities that challenge balance and mobility, such as standing on one foot, reaching for objects, and turning in place. Each task is scored on a scale ranging from 0 to 4, with 0 indicating the lowest level of performance and 4 indicating the highest level of performance

    Measured: week 0 and week 6

  3. Stroke Specific Quality of Life Scale

    Stroke Specific Quality of Life Scale (SS-QOL) is a specialized assessment tool designed to measure the quality of life in individuals who have experienced a stroke. This scale is specifically tailored to evaluate the impact of stroke on various aspects of a person's life, encompassing physical, psychological, and social domains. The SS-QOL questionnaire typically consists of multiple items or questions that cover a range of topics, including physical health, mobility, communication abilities, emotional well-being, and social relationships. Respondents rate their level of satisfaction or well-being in each domain, often on a scale from 0 to 5 or 0 to 100, with higher scores indicating better quality of life

    Measured: week 0 and week 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2024
  2. Study start12 Nov 2024
  3. Primary completion13 Jul 2025 (estimated)
  4. Study completion13 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06692569
Sponsor's protocol ID
MUREC-May.22/COM-2022/6-1
Acronym
mCIMT
Status last verified
Nov 2024
First submitted
14 Nov 2024
Last updated
18 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • M Shahhar A, Shaik AR, Esht V, Alshehri MM, Balasubramanian K, Ramasamy Sanjeevi R, Abdulrahman Alfaleh K, Okab Alsalem W, Fathi WA, A Alothman S. Modified Constraint-Induced Movement Therapy with Trunk Restraint for Upper Extremity Functional Motor Recovery, Balance and Health-Related Quality of Life in Chronic Stroke: A Single-Blinded Randomized Controlled Clinical Trial. NeuroRehabilitation. 2026 May;58(3):413-428. doi: 10.1177/10538135261417372. Epub 2026 Feb 2.

    PubMed 41627128

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Physical Therapy and Modified Constraint Induced Movement Therapy in people with Stroke and Hemiplegia, run by University of Jazan at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mohammed Mansour Al Shehri, PhD (00966-503946253, moalshehri@jazanu.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wolf Motor Function Test (time frame: Week 0 and week 6). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06692569, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in